Jefferies analyst Chris Howerton downgrades Compugen (NASDAQ:CGEN) from Buy to Hold and announces $2 price target.
Incannex Healthcare To Open First Psychedelic-Assisted Therapy Clinic In Australia
Melbourne will soon open Clarion Clinics’ first exclusively dedicated facility to provide psychedelic-assisted therapies legalized in Australia.